| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
University of Würzburg (H.-Y.L., M.J.H., H.M.R.), Institute for Virology and Immunobiology, 97078 Würzburg, Germany; University of Göttingen (J.v.d.B., H.M.R.), Medical School, Department of Cellular and Molecular Immunology, 37073 Göttingen, Germany; and University of Würzburg (M.F., B.A.), Department of Internal Medicine I, Endocrine and Diabetes Unit, 97080 Würzburg, Germany
Address all correspondence and requests for reprints to: Prof. Dr. Holger Reichardt, University of Göttingen, Medical School, Department of Cellular and Molecular Immunology, Humboldtallee 34, 37073 Göttingen, Germany. E-mail: hreichardt{at}med.uni-goettingen.de.
Currently, gene disruption by homologous recombination in embryonic stem cells is only feasible in mice. To circumvent this problem, we silenced mineralocorticoid receptor (MR) expression by RNA interference in knockdown rats generated through lentiviral transgenesis. Analysis of the F1 progeny at 3 wk of age revealed strongly decreased MR levels. This was specific for the targeted gene and related to the abundance of the short interfering RNA. Reminiscent of MR knockout mice, the transgenic rats showed a reduced body weight, elevated serum aldosterone levels, increased plasma renin activity, and altered expression of MR target genes. Some of these effects correlated with the degree to which MR mRNA expression was reduced. Whereas disruption of the MR by gene targeting in mice leads to postnatal death, our strategy also allowed obtaining adult knockdown rats with defects in hormone and electrolyte homeostasis resembling pseudohypoaldosteronism. In conclusion, this is the first example of a human disease model based on RNA interference in rats.
NURSA Molecule Pages Link:
This article has been cited by other articles:
![]() |
M. J. Herold, J. van den Brandt, J. Seibler, and H. M. Reichardt Inducible and reversible gene silencing by stable integration of an shRNA-encoding lentivirus in transgenic rats PNAS, November 25, 2008; 105(47): 18507 - 18512. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |